TMDX (TransMedics Organ Care System) Prakiraan pendapatan perusahaan
TransMedics Group (TMDX) possesses exceptional pricing power thanks to its vital OCS system. The company's monopoly status is confirmed by the willingness of clinics to cover any costs to save patients. Revenues are based on the sale of perfusion systems and organ logistics. The company's expected sales volume on this chart demonstrates market prospects, and 0.43 determines the latest valuation metric.
Rincian analitis lan laporan data perusahaan TransMedics Group Inc (TMDX)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal TransMedics Group|TMDX - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal TransMedics Corp|TMDX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku TransMedics Group Inc|TMDX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan TransMedics|Indikator likuiditas cepet transmedics.com
- statistik bathi lan rasio pasar:
TMDX - Bathi pungkasan|Proyeksi bathi mangsa ngarep TransMedics Group|TMDX - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep transmedics.com|TMDX - Rasio rega marang wutah bathi resik|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan TransMedics Group Inc|TMDX - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) TransMedics|TMDX - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan transmedics.com|TMDX - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep TransMedics Group
- data dodolan lan asil:
Analisis fundamental perusahaan:TransMedics Group
The innovative approach of TransMedics Group (TMDX) management to transforming organ logistics directly determines the dynamics of the company's projected revenue. This indicator aggregates simulated market proceeds, allowing investors to assess the fundamental value of the business and identify risk asymmetry through an analysis of the capital recovery rate, where each value may signal either upcoming growth or a deepening correction.
Analisis perusahaan pesaing
Volume dodolan mangsa ngarep perusahaan BSX (Boston Scientific)|EW (edwards.com) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan ResMed RMD|PODD - Volume dodolan mangsa ngarep perusahaan|Zimmer - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan CooperSurgical|ALGN: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GMED|ATEC (Alphatec) - Prakiraan volume dodolan|CryoLife (AORT) - Dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan ENOV|Volume dodolan mangsa ngarep perusahaan Integra LifeSciences Inc. IART|Prakiraan volume dodolan ESTA (Establishment Labs)|Prakiraan volume dodolan betabionics.com BBNX|IRMD - Prakiraan pendapatan perusahaan|EMBC: Prakiraan pendapatan perusahaan|TNDM (Tandem Diabetes) - Volume dodolan mangsa ngarep perusahaan|Axogen Surgical - Pendapatan mangsa ngarep perusahaan|SIBN (SI-BONE, Inc.) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan orthofix.com OFIX|Prakiraan pendapatan perusahaan Bioventus (BVS)|orthopediatrics.com (KIDS) - Prakiraan dodolan perusahaan|Treace Medical - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan Strata Medical SRTA|Carlsmed Inc - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan rxsight.com RXST|clearpointneuro.com (CLPT) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan STXS (Stereotaxis Inc)|Prakiraan pendapatan perusahaan NeuroStar|Volume dodolan mangsa ngarep perusahaan Sight Sciences Inc (SGHT)|Prakiraan volume dodolan OBIO|ANIK - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan InspireMD NSPR|ZJYL: Prakiraan pendapatan perusahaan|VANI: Volume dodolan mangsa ngarep perusahaan|Xtant Medical Holdings - Prakiraan volume pendapatan perusahaan|NMTC (NeuroOne Medical Technologies) - Volume dodolan mangsa ngarep perusahaan|MODD: Prakiraan volume pendapatan perusahaan|Prakiraan pendapatan perusahaan Myomo|COCH: Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan VVOS|Prakiraan volume dodolan enVVeno Corp (NVNO)|Prakiraan pendapatan perusahaan Sintx Technologies, Inc. SINT|TNON: Prakiraan pendapatan perusahaan|LFWD - Prakiraan pendapatan perusahaan|Dodolan mangsa ngarep perusahaan Autonomix Medical, Inc. AMIX|INVO Bioscience, Inc. (IVF) - Prakiraan pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan Bone Biologics Inc|AXNX (Axonics, Inc.) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan biolase.com BIOL|Prakiraan volume dodolan DYNT|paragon28.com - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan INVO (INVO Bioscience)
